Patients living with sickle cell disease and thalassaemia will be eligible for the test
Category: News
Autosomal dominant polycystic kidney disease affects more than 12 million people globally
Approximately 48,000 deaths in the UK occur from sepsis every year
Approximately one in five children will be hospitalised to treat measles
Company will present vital findings at SRI annual meeting
New stroke therapy delivers electrical pulses to the brain
Green light concerns generalised myasthenia gravis therapy
Company is focused on endocannabinoid system treatments
Data supports Poolbeg’s strategic expansion of POLB 001